CVS
CVS Health Corporation$81.27+2.92 (+3.72%)Prev Close$78.36·MCap$97.43B·P/E56.91·Vol4.21M·Yield0.03%
▲
Buys (12M)
2
$104.6K
▼
Sells (12M)
9
$257.79M
◆
Net Activity
Net Seller
$257.68M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at CVS Health Corporation (CVS) has been dominated by selling, with 2 insider purchases totaling $104.6K and 9 insider sales totaling $257.79M. The most recent insider transaction was by Shah Prem S (EVP and Group President), who sold $19.8K worth of shares on Jan 5, 2026. CVS Health Corporation operates in the Healthcare sector, within the Medical - Healthcare Plans industry, with a market cap of $97.43B.
CVS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Shah Prem S | EVP and Group President | Sell | 247 | $80.13 | $19.8K | 0 |
| Dec 2, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | Sell | 9,470 | $80.36 | $761.0K | 0 |
| Dec 2, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 6,575 | $80.36 | $528.4K | 0 |
| Dec 1, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 220 | $79.10 | $17.4K | 0 |
| Nov 30, 2025 | FARAH ROGER N | Director | Sell | 9,748 | $80.36 | $783.3K | 0 |
| Oct 14, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | Buy | 80 | $57.36 | $4.6K | 0 |
| Sep 2, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 12,834 | $73.15 | $938.8K | 0 |
| Sep 2, 2025 | Shah Prem S | EVP and Group President | Sell | 6,995 | $73.15 | $511.7K | 0 |
| Aug 20, 2025 | Finucane Anne A. | Director | Sell | 7,500 | $71.02 | $532.6K | 0 |
| Jun 9, 2025 | SANSONE GUY P | Director | Buy | 1,570 | $63.70 | $100.0K | 0 |
| May 6, 2025 | ROBBINS LARRY | Director | Sell | 3,750,000 | $67.65 | $253.69M | 0 |
| Apr 3, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 2,266 | $67.98 | $154.0K | 0 |
| Apr 3, 2025 | COWHEY THOMAS F. | EVP and CFO | Sell | 3,203 | $67.98 | $217.7K | 0 |
| Apr 3, 2025 | Joyner J. David | President and CEO | Sell | 1,847 | $67.98 | $125.6K | 0 |
| Apr 3, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 1,548 | $67.98 | $105.2K | 0 |
| Apr 3, 2025 | Mandadi Tilak | EVP, Chief Experience & Tech | Sell | 995 | $67.98 | $67.6K | 0 |
| Apr 3, 2025 | Shah Prem S | EVP and Group President | Sell | 1,308 | $67.98 | $88.9K | 0 |
| Mar 7, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 7,513 | $66.35 | $498.5K | 0 |
| Mar 3, 2025 | COWHEY THOMAS F. | EVP and CFO | Sell | 5,318 | $65.72 | $349.5K | 0 |
| Mar 3, 2025 | Joyner J. David | President and CEO | Sell | 1,944 | $65.72 | $127.8K | 0 |
| Mar 3, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 5,604 | $65.72 | $368.3K | 0 |
| Feb 19, 2025 | Mahoney Michael F | Director | Buy | 30,000 | $66.70 | $2.00M | 0 |
| Jan 23, 2025 | Nelson Steven H | EVP and President, Aetna | Buy | 24 | $53.70 | $1.3K | 0 |
| Nov 30, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 86 | $59.85 | $5.1K | 0 |
| Aug 31, 2024 | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,097 | $57.24 | $749.7K | 0 |
| May 2, 2024 | LUDWIG EDWARD J | Director | Buy | 1,000 | $53.88 | $53.9K | 0 |
| May 2, 2024 | Mahoney Michael F | Director | Buy | 9,181 | $54.49 | $500.3K | 0 |
| Apr 1, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 2,298 | $79.56 | $182.8K | 0 |
| Apr 1, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 3,004 | $79.56 | $239.0K | 0 |
| Apr 1, 2024 | COWHEY THOMAS F. | EVP and CFO | Sell | 1,719 | $79.56 | $136.8K | 0 |
| Apr 1, 2024 | Havanec Laurie P. | EVP and Chief People Officer | Sell | 7,630 | $79.56 | $607.0K | 0 |
| Apr 1, 2024 | Lynch Karen S | President and CEO | Sell | 61,953 | $79.56 | $4.93M | 0 |
| Apr 1, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 7,892 | $79.56 | $627.9K | 0 |
| Feb 28, 2024 | COWHEY THOMAS F. | SVP, Interim CFO | Sell | 5,641 | $75.19 | $424.1K | 0 |
| Feb 28, 2024 | Joyner J. David | EVP&President-PharmacyServices | Sell | 1,970 | $75.19 | $148.1K | 0 |
| Feb 28, 2024 | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 6,210 | $75.19 | $466.9K | 0 |
| Feb 26, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 355 | $76.43 | $27.1K | 0 |
| Feb 26, 2024 | Havanec Laurie P. | EVP and Chief People Officer | Sell | 6,698 | $76.43 | $511.9K | 0 |
| Feb 26, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 261 | $76.43 | $19.9K | 0 |
| Feb 16, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 29,473 | $76.95 | $2.27M | 0 |
| Dec 14, 2023 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 122 | $68.48 | $8.4K | 0 |
| Nov 3, 2023 | LUDWIG EDWARD J | Director | Buy | 2,000 | $70.47 | $140.9K | 0 |
| Aug 31, 2023 | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,053 | $65.17 | $850.7K | 0 |
| Aug 31, 2023 | Shah Prem S | EVP and Co-President of Retail | Sell | 3,508 | $65.17 | $228.6K | 0 |
| Aug 3, 2023 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 25,759 | $74.93 | $1.93M | 0 |
| May 3, 2023 | Lynch Karen S | President and CEO | Buy | 14,000 | $69.75 | $976.6K | 0 |
| Apr 1, 2023 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 1,854 | $74.31 | $137.8K | 0 |
| Apr 1, 2023 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 1,471 | $74.31 | $109.3K | 0 |
| Apr 1, 2023 | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 3,856 | $74.31 | $286.5K | 0 |
| Apr 1, 2023 | Lynch Karen S | President and CEO | Sell | 93,677 | $74.31 | $6.96M | 0 |
Showing 1–50 of 120
1 / 3
CVS Insider Buying Activity
The following table shows recent insider purchases of CVS Health Corporation (CVS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | Buy | 80 | $57.36 | $4.6K | 0 |
| Jun 9, 2025 | SANSONE GUY P | Director | Buy | 1,570 | $63.70 | $100.0K | 0 |
| Feb 19, 2025 | Mahoney Michael F | Director | Buy | 30,000 | $66.70 | $2.00M | 0 |
| Jan 23, 2025 | Nelson Steven H | EVP and President, Aetna | Buy | 24 | $53.70 | $1.3K | 0 |
| May 2, 2024 | LUDWIG EDWARD J | Director | Buy | 1,000 | $53.88 | $53.9K | 0 |
| May 2, 2024 | Mahoney Michael F | Director | Buy | 9,181 | $54.49 | $500.3K | 0 |
| Nov 3, 2023 | LUDWIG EDWARD J | Director | Buy | 2,000 | $70.47 | $140.9K | 0 |
| May 3, 2023 | Lynch Karen S | President and CEO | Buy | 14,000 | $69.75 | $976.6K | 0 |
CVS Insider Selling Activity
The following table shows recent insider sales of CVS Health Corporation (CVS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Shah Prem S | EVP and Group President | Sell | 247 | $80.13 | $19.8K | 0 |
| Dec 2, 2025 | CAPOZZI HEIDI B | EVP and Chief People Officer | Sell | 9,470 | $80.36 | $761.0K | 0 |
| Dec 2, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 6,575 | $80.36 | $528.4K | 0 |
| Dec 1, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 220 | $79.10 | $17.4K | 0 |
| Nov 30, 2025 | FARAH ROGER N | Director | Sell | 9,748 | $80.36 | $783.3K | 0 |
| Sep 2, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 12,834 | $73.15 | $938.8K | 0 |
| Sep 2, 2025 | Shah Prem S | EVP and Group President | Sell | 6,995 | $73.15 | $511.7K | 0 |
| Aug 20, 2025 | Finucane Anne A. | Director | Sell | 7,500 | $71.02 | $532.6K | 0 |
| May 6, 2025 | ROBBINS LARRY | Director | Sell | 3,750,000 | $67.65 | $253.69M | 0 |
| Apr 3, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 2,266 | $67.98 | $154.0K | 0 |
| Apr 3, 2025 | COWHEY THOMAS F. | EVP and CFO | Sell | 3,203 | $67.98 | $217.7K | 0 |
| Apr 3, 2025 | Joyner J. David | President and CEO | Sell | 1,847 | $67.98 | $125.6K | 0 |
| Apr 3, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 1,548 | $67.98 | $105.2K | 0 |
| Apr 3, 2025 | Mandadi Tilak | EVP, Chief Experience & Tech | Sell | 995 | $67.98 | $67.6K | 0 |
| Apr 3, 2025 | Shah Prem S | EVP and Group President | Sell | 1,308 | $67.98 | $88.9K | 0 |
| Mar 7, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 7,513 | $66.35 | $498.5K | 0 |
| Mar 3, 2025 | COWHEY THOMAS F. | EVP and CFO | Sell | 5,318 | $65.72 | $349.5K | 0 |
| Mar 3, 2025 | Joyner J. David | President and CEO | Sell | 1,944 | $65.72 | $127.8K | 0 |
| Mar 3, 2025 | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 5,604 | $65.72 | $368.3K | 0 |
| Nov 30, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 86 | $59.85 | $5.1K | 0 |
| Aug 31, 2024 | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,097 | $57.24 | $749.7K | 0 |
| Apr 1, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 2,298 | $79.56 | $182.8K | 0 |
| Apr 1, 2024 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 3,004 | $79.56 | $239.0K | 0 |
| Apr 1, 2024 | COWHEY THOMAS F. | EVP and CFO | Sell | 1,719 | $79.56 | $136.8K | 0 |
| Apr 1, 2024 | Havanec Laurie P. | EVP and Chief People Officer | Sell | 7,630 | $79.56 | $607.0K | 0 |
| Apr 1, 2024 | Lynch Karen S | President and CEO | Sell | 61,953 | $79.56 | $4.93M | 0 |
| Apr 1, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 7,892 | $79.56 | $627.9K | 0 |
| Feb 28, 2024 | COWHEY THOMAS F. | SVP, Interim CFO | Sell | 5,641 | $75.19 | $424.1K | 0 |
| Feb 28, 2024 | Joyner J. David | EVP&President-PharmacyServices | Sell | 1,970 | $75.19 | $148.1K | 0 |
| Feb 28, 2024 | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 6,210 | $75.19 | $466.9K | 0 |
| Feb 26, 2024 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 355 | $76.43 | $27.1K | 0 |
| Feb 26, 2024 | Havanec Laurie P. | EVP and Chief People Officer | Sell | 6,698 | $76.43 | $511.9K | 0 |
| Feb 26, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 261 | $76.43 | $19.9K | 0 |
| Feb 16, 2024 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 29,473 | $76.95 | $2.27M | 0 |
| Dec 14, 2023 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 122 | $68.48 | $8.4K | 0 |
| Aug 31, 2023 | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,053 | $65.17 | $850.7K | 0 |
| Aug 31, 2023 | Shah Prem S | EVP and Co-President of Retail | Sell | 3,508 | $65.17 | $228.6K | 0 |
| Aug 3, 2023 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 25,759 | $74.93 | $1.93M | 0 |
| Apr 1, 2023 | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 1,854 | $74.31 | $137.8K | 0 |
| Apr 1, 2023 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 1,471 | $74.31 | $109.3K | 0 |
| Apr 1, 2023 | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 3,856 | $74.31 | $286.5K | 0 |
| Apr 1, 2023 | Lynch Karen S | President and CEO | Sell | 93,677 | $74.31 | $6.96M | 0 |
CVS Insiders
Similar Stocks to CVS
UNH
UnitedHealth Group Incorporated
$368.12+3.76%
$293.62B
ELV
Elevance Health Inc.
$364.95+2.38%
$70.48B
HUM
Humana Inc.
$232.90+4.24%
$26.21B
MOH
Molina Healthcare, Inc.
$188.80+5.35%
$7.95B
OSCR
Oscar Health, Inc.
$17.96+4.45%
$4.36B
ALHC
Alignment Healthcare, Inc.
$21.77+3.91%
$4.32B
CLOV
Clover Health Investments, Corp.
$2.55+1.39%
$1.23B